For observations in patients at risk for HCC. Set the size, arterial enhancement, and additional features.
First, rule out these — select if present
Nonrim arterial phase hyperenhancement (APHE)
Observation size
mm
Additional major features — select all present
Enter features
Set APHE, size and any additional features.
CT/MRI LI-RADS v2018 diagnostic table. Apply only in at-risk patients; threshold growth = ≥50% size increase in ≤6 months. Decision support only — not a substitute for clinical judgment.
ACR Liver Imaging Reporting and Data System (LI-RADS) CT/MRI v2018.